Blog
Plasma Protease C1-Inhibitor Market to Reach USD 9.06 Billion by 2032 as Rare Disease Awareness Accelerates
Expanding Rare Disease Recognition Strengthens Market Growth Trajectory The plasma protease C1-inhibitor market, valued at USD 4.18 billion in 2024, is forecasted to achieve USD
SNS Insider
November 27, 2025